Phase 1 study of pandemic H1 DNA vaccine in healthy adults
about
Refining the approach to vaccines against influenza A viruses with pandemic potential.Receptor-binding domain of MERS-CoV with optimal immunogen dosage and immunization interval protects human transgenic mice from MERS-CoV infection.Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost.An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trial.Universal Vaccines and Vaccine Platforms to Protect against Influenza Viruses in Humans and Agriculture.New Vaccine Technologies to Combat Outbreak SituationsA Review of DNA Vaccines Against Influenza
P2860
Q30381595-E1299F43-FD49-43BB-8895-A42CA7E8E07BQ30399700-2CF195B3-EAB3-41B1-B82C-E78DCF535587Q36573064-1E744F05-FC2D-42C4-9787-9DCC7859058BQ47105782-0524FB12-4D2F-465C-ABFA-5337A899A45DQ50308620-2CC661AC-5D54-4896-8DDA-A16FF813CB36Q57072744-FEB83406-BBF9-4DFF-9AE0-C1CB90F6AD8AQ57094261-A40F9CF5-3C33-4B6F-B0E6-D57BB1C4939D
P2860
Phase 1 study of pandemic H1 DNA vaccine in healthy adults
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Phase 1 study of pandemic H1 DNA vaccine in healthy adults
@ast
Phase 1 study of pandemic H1 DNA vaccine in healthy adults
@en
type
label
Phase 1 study of pandemic H1 DNA vaccine in healthy adults
@ast
Phase 1 study of pandemic H1 DNA vaccine in healthy adults
@en
prefLabel
Phase 1 study of pandemic H1 DNA vaccine in healthy adults
@ast
Phase 1 study of pandemic H1 DNA vaccine in healthy adults
@en
P2093
P2860
P50
P1433
P1476
Phase 1 study of pandemic H1 DNA vaccine in healthy adults
@en
P2093
Galina V Yamshchikov
Ingelise J Gordon
LaSonji A Holman
Mary E Enama
Michelle C Crank
Richard A Koup
Richard M Schwartz
Robert T Bailer
Sandra Sitar
VRC 308 Study Team
P2860
P304
P356
10.1371/JOURNAL.PONE.0123969
P407
P577
2015-04-17T00:00:00Z